Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Nav1.7 blockers(Sodium channel protein type IX alpha subunit blockers), Nav1.8 blockers(Sodium channel protein type X alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization Drug Hunter, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H15F4N3O2 |
InChIKeyFWLFRXVPNVBXGR-CQSZACIVSA-N |
CAS Registry1802848-94-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | US | Drug Hunter, Inc.Startup | 13 May 2022 |